Literature DB >> 14710852

Over-expression of cyclin D1 regulates Cdk4 protein synthesis.

M A Parker1, N G Deane, E A Thompson, R H Whitehead, S K Mithani, M K Washington, P K Datta, D A Dixon, R D Beauchamp.   

Abstract

Increased Cdk4 expression occurs coincident with over-expression of cyclin D1 in many human tumours and tumourigenic mouse models. Here, we investigate both in vivo and in vitro the mechanism by which Cdk4 expression is regulated in the context of cyclin D1 over-expression. Cdk4 mRNA levels in cyclin D1-over-expressing tissue and cultured cells were unchanged compared with controls. In contrast, Cdk4 protein levels were increased in cyclin D1-over-expressing tissue and cells versus their respective controls. This increase was not due to altered protein stability, but appeared to be due to an increase in Cdk4 protein synthesis. We also performed immunoprecipitation and in vitro kinase assays to demonstrate an increase in cyclin D1-Cdk4 complex formation and associated kinase activity. Blocking cyclin D1 expression resulted in diminished Cdk4 protein but not mRNA levels. These findings suggest a mechanism by which Cdk4 expression is increased in the context of cyclin D1 over-expression during tumourigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14710852      PMCID: PMC6496860          DOI: 10.1046/j.1365-2184.2003.00290.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  36 in total

1.  Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas.

Authors:  V Masciullo; G Scambia; M Marone; C Giannitelli; G Ferrandina; A Bellacosa; P Benedetti Panici; S Mancuso
Journal:  Int J Cancer       Date:  1997-08-22       Impact factor: 7.396

2.  Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas.

Authors:  Y Dong; L Sui; K Sugimoto; Y Tai; M Tokuda
Journal:  Int J Cancer       Date:  2001-07-20       Impact factor: 7.396

3.  Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines.

Authors:  K Kitahara; W Yasui; H Yokozaki; S Semba; T Hamamoto; T Hisatsugu; E Tahara
Journal:  J Exp Ther Oncol       Date:  1996-01

4.  Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients.

Authors:  T Zhang; L B Nanney; C Luongo; L Lamps; K J Heppner; R N DuBois; R D Beauchamp
Journal:  Cancer Res       Date:  1997-01-01       Impact factor: 12.701

5.  Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum.

Authors:  M Kornmann; N Arber; M Korc
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

6.  TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest.

Authors:  M E Ewen; H K Sluss; L L Whitehouse; D M Livingston
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

7.  Overexpression of cyclin D1 and cdk4 in tumorigenesis of sporadic hepatoblastomas.

Authors:  H Kim; E K Ham; Y I Kim; J G Chi; H S Lee; S H Park; Y M Jung; N K Myung; M J Lee; J J Jang
Journal:  Cancer Lett       Date:  1998-09-25       Impact factor: 8.679

8.  p53-dependent repression of CDK4 translation in TGF-beta-induced G1 cell-cycle arrest.

Authors:  M E Ewen; C J Oliver; H K Sluss; S J Miller; D S Peeper
Journal:  Genes Dev       Date:  1995-01-15       Impact factor: 11.361

9.  Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.

Authors:  W Jiang; Y J Zhang; S M Kahn; M C Hollstein; R M Santella; S H Lu; C C Harris; R Montesano; I B Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

10.  Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.

Authors:  G I Shapiro; C D Edwards; L Kobzik; J Godleski; W Richards; D J Sugarbaker; B J Rollins
Journal:  Cancer Res       Date:  1995-02-01       Impact factor: 12.701

View more
  4 in total

1.  Co-suppression of VEGF-A and VEGF-C inhibits development of experimental hemangioma.

Authors:  Chongqing Huang; Jingyong Huang; Guanfeng Yu
Journal:  Am J Transl Res       Date:  2018-09-15       Impact factor: 4.060

2.  Benzo[a]pyrene-induced cell cycle progression is through ERKs/cyclin D1 pathway and requires the activation of JNKs and p38 mapk in human diploid lung fibroblasts.

Authors:  Hong Ju Du; Ning Tang; Bing Ci Liu; Bao Rong You; Fu Hai Shen; Meng Ye; Ai Gao; Chuan shu Huang
Journal:  Mol Cell Biochem       Date:  2006-05-13       Impact factor: 3.396

3.  Syncytin-1 modulates placental trophoblast cell proliferation by promoting G1/S transition.

Authors:  Qiang Huang; Jinping Li; Fengchao Wang; Matthew T Oliver; Tracy Tipton; Ya Gao; Shi-Wen Jiang
Journal:  Cell Signal       Date:  2013-01-16       Impact factor: 4.315

4.  Activation of ribosomal RNA transcription by hepatitis C virus involves upstream binding factor phosphorylation via induction of cyclin D1.

Authors:  Santanu Raychaudhuri; Vanessa Fontanes; Bhaswati Barat; Asim Dasgupta
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.